NCT06416085 2026-03-05
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
University Health Network, Toronto
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT06200155 2026-03-03
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06801041 2026-03-03
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06827054 2026-02-18
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
NCT04950608 2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2 Completed
NCT07216404 2026-02-10
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT07336238 2026-02-09
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
Phase 2 Not yet recruiting
NCT06001749 2025-12-16
Psilocybin in Cancer Pain Study
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT07048743 2025-07-11
PEARL-C1
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT04593563 2021-10-15
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Maryland Oncology Hematology, PA
Phase 2 Unknown
NCT00465595 2018-07-19
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Phase 2 Completed